Search for: "Predictive Therapeutic LLC" Results 1 - 20 of 36
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Dec 2020, 3:06 am
"]January 19, 2021 - 11 AM: In re Spark Therapeutics, Inc., Serial No. 87614019 [Section 2(d) refusal of SPARK THERAPEUTICS GENERATION PATIENT SERVICES for, inter alia, providing information for patients, families and health care providers about health care insurance coverage and insurance reimbursement programs [THERAPEUTICS and PATIENT SERVICES disclaimed], in view of the registered mark SPARQ & Design for "Providing health information services, namely,… [read post]
29 Mar 2019, 3:13 am
April 9, 2019 - 1 PM: OnePoint Patient Care, LLC v. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Acorda Therapeutics, et al., No. 16-360 (does an ANDA filing create nationwide specific jurisdiction?) [read post]
14 Feb 2010, 4:20 pm by Aaron Barkoff
  The ‘318 patent claims “a method of treating Alzheimer’s disease and related dementias which comprises administering . . . a therapeutically effective amount of glanthamine. . . . [read post]
14 Jul 2008, 9:17 am
Cir. 2001)); accord PharmaStem Therapeutics, Inc. v. [read post]
10 May 2011, 10:25 am by Tomassi Law Associates
Updates Molecular Insight Confirms Bondholders’ Reorganization Plan Molecular Insight Pharmaceuticals Inc., a developer of therapeutic and imaging radiopharmaceuticals for cancer treatment, proposed a reorganization plan that was opposed by holders of $201.8 million in secured bonds. [read post]
The Federal Circuit concurred with the district court finding that the improved stability was a difference in “degree” and a predictable effect of altering PVP content. [read post]
16 Mar 2021, 6:00 am by Jason Rantanen
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
17 Jul 2022, 5:00 am by Dennis Crouch
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
3 May 2024, 6:38 am by Holly
For example, according to the fact pattern, the data provided by Raghu was from a well-known cancer-related compound data set provided by the National Cancer Institute, i.e. it was not a new source of data.[19] Furthermore, the DNN that performed the processing was a ready-to-use system that can predict the strength of interaction between drug-target pairs, i.e. there was no new technique for analyzing the provided data.[20] Based on these two factors, it appears our limitation contains… [read post]
6 Jan 2023, 9:01 am by Overhauser Law Offices, LLC
Overhauser Law Offices LLC, the publisher of this site, assists with US and foreign patent searches, patent applications and assists with enforcing patents via infringement litigation and licensing. [read post]